- 1Department of Breast Surgery, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
- 2The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
- 3Department of General Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China
- 4Key Laboratory of Tumor Molecular Pathology of Baise, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China
A Correction on
Exposing the cellular situation: findings from single-cell RNA sequencing in breast cancer
By Ni G, Li X, Nie W, Zhao Z, Li H and Zang H (2025). Front. Immunol. 16:1539074. doi: 10.3389/fimmu.2025.1539074
There was a mistake in Figure 7F as published. We mistakenly wrote CEBPD in Figure 7F as EGFR. The corrected Figure 7F appears below.
Figure 7. In vitro experimental validation of CEBPD. (A) After CEBPD knock-down, the expression levels of mRNA and protein decreased significantly. (B) CCK-8 detection showed that compared with the control group, the cell viability was significantly decreased after CEBPD knock-down. (C, D) The colony formation assay showed that the number of colonies decreased significantly after CEBPD was knocked down. (E) Scratch test showed that CEBPD knockdown inhibited cell migration. (F) EDU staining confirmed that CEBPD knock-down had inhibitory effect on cell proliferation. (G) Bar chart showed that the ability of cell migration and proliferation decreased significantly after CEBPD. (H, I) Transwell experiment showed that CEBPD knockdown inhibited the migration and invasion of TCs in BT-549 and MDA-MB-436 cell lines. *, p < 0.05; **, p < 0.0 1; ***, p < 0.001 indicates a significant difference, and NS indicates a non-significant difference.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: single cell RNA sequencing, breast cancer, CEBPD, transcription factors, tumor microenvironment, metabolism
Citation: Ni G, Li X, Nie W, Zhao Z, Li H and Zang H (2025) Correction: Exposing the cellular situation: findings from single-cell RNA sequencing in breast cancer. Front. Immunol. 16:1709624. doi: 10.3389/fimmu.2025.1709624
Received: 20 September 2025; Accepted: 17 October 2025;
Published: 24 October 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Ni, Li, Nie, Zhao, Li and Zang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhenzhen Zhao, MjAyMzExMDc5NUBzZHV0Y20uZWR1LmNu; Hua Li, bGlodWFfZ3hAeW11bi5lZHUuY24=; Hongyan Zang, MjQyMDA4Mjk4OEBxcS5jb20=
†These authors have contributed equally to this work and share first authorship
Hongyan Zang1*